Long term efficacy of Bosentan in the therapy of systemic sclerosis associated pulmonary arterial hypertension

被引：0
|
作者：
Iannone, F [1 ]
Riccardi, MT [1 ]
Chialà, A [1 ]
Anelli, MG [1 ]
Conforti, ML [1 ]
Guiducci, S [1 ]
Albanese, L [1 ]
Cerinic, MM [1 ]
Lapadula, G [1 ]
机构：
[1] Univ Bari, Rheumatol Unit, Bari, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：301 / 301
页数：1
相关论文
共 50 条
  • [41] Bosentan in pulmonary artery hypertension secondary to systemic sclerosis
    Joglekar, A
    Fausan, FB
    McCloskey, DA
    Wilson, JE
    Seibold, JR
    Riley, DJ
    [J]. CHEST, 2003, 124 (04) : 223S - 223S
  • [42] Bosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia
    Bonderman, D.
    Nowotny, R.
    Skoro-Sajer, N.
    Adlbrecht, C.
    Lang, I. M.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 71 - 72
  • [43] Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
    Launay, David
    Sitbon, Olivier
    Le Pavec, Jerome
    Savale, Laurent
    Tcherakian, Colas
    Yaici, Azzedine
    Achouh, Lara
    Parent, Florence
    Jais, Xavier
    Simonneau, Gerald
    Humbert, Marc
    [J]. RHEUMATOLOGY, 2010, 49 (03) : 490 - 500
  • [44] Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension
    Provencher, S
    Sitbon, O
    Humbert, M
    Cabrol, S
    Jaïs, X
    Simonneau, G
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (05) : 589 - 595
  • [45] Long-term bosentan treatment in children with pulmonary arterial hypertension - Reply
    Rosenzweig, EB
    Ivy, DD
    Widlitz, A
    Doran, A
    Claussen, LR
    Yung, D
    Abman, SH
    Barst, RJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) : 1915 - 1915
  • [46] The bosentan patient registry: long-term survival in pulmonary arterial hypertension
    Keogh, A.
    Strange, G.
    McNeil, K.
    Williams, T. J.
    Gabbay, E.
    Proudman, S.
    Weintraub, R. G.
    Wlodarczyk, J.
    Dalton, B.
    [J]. INTERNAL MEDICINE JOURNAL, 2011, 41 (03) : 227 - 234
  • [47] Efficacy and Safety of Long-Term Imatinib Therapy for Pulmonary Arterial Hypertension
    Speich, Rudolf
    Ulrich, Silvia
    Domenighetti, Guido
    Huber, Lars C.
    Fischler, Manuel
    Treder, Ursula
    Breitenste, Alexander
    [J]. RESPIRATION, 2015, 89 (06) : 515 - 524
  • [48] Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension - Long-term efficacy and combination with bosentan
    Benza, Raymond L.
    Rayburn, Barry K.
    Tallaj, Jose A.
    Pamboukian, Salpy V.
    Bourge, Robert C.
    [J]. CHEST, 2008, 134 (01) : 139 - 145
  • [49] Alprostadil therapy for pulmonary arterial hypertension related to systemic sclerosis
    Yatsyshyn, R.
    Neyko, Ye.
    Yatsyshyn, N.
    [J]. JOURNAL OF HYPERTENSION, 2007, 25 : S114 - S114
  • [50] Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta-analysis
    Chen, Xinwang
    Zhai, Zhenguo
    Huang, Ke
    Xie, Wanmu
    Wan, Jun
    Wang, Chen
    [J]. CLINICAL RESPIRATORY JOURNAL, 2018, 12 (06): : 2065 - 2074
12345